Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (371-380 of 377) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 377 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2021
Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2021
Correction to: Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Radiology|April 28, 2026
<sup>177</sup>Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate CancerNarjess Ayati, Nathan Papa, Megan Crumbaker, et al.
JCO Clinical Cancer Informatics|November 9, 2020
Joint Imaging Platform for Federated Clinical Data AnalyticsJonas Scherer, Marco Nolden, Jens Kleesiek, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 38

Showing results (371-380 of 377) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 377 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2021
Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2021
Correction to: Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Radiology|April 28, 2026
<sup>177</sup>Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate CancerNarjess Ayati, Nathan Papa, Megan Crumbaker, et al.
JCO Clinical Cancer Informatics|November 9, 2020
Joint Imaging Platform for Federated Clinical Data AnalyticsJonas Scherer, Marco Nolden, Jens Kleesiek, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 38